Form 4: AVITA Medical Director Acquires Shares

AVITA Medical Director Joseph F. Woody acquired a total of 20,000 shares of common stock across multiple transactions on June 1st and 2nd, 2026.

Summary

• Director Joseph F. Woody acquired 20,000 shares of AVITA Medical common stock through several transactions between June 1 and June 2, 2026.
• The acquisitions were made at prices ranging from $4.1802 to $4.34 per share.
• Following these transactions, Mr. Woody beneficially owns 20,000 shares of common stock.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing due to the director's acquisition of shares, indicating confidence, but lacking broader financial or strategic information.

Positives

• Director's increased stake in the company suggests confidence in AVITA Medical's future prospects.
• Acquisition of shares by a director can be interpreted as a positive signal to the market.

Future Outlook

No specific forward-looking statements or guidance are present in this filing, which solely reports on insider transactions.

Industry Context

StockSavvy.ai notes that insider purchases, particularly by directors, are often viewed as a sign of management's belief in the company's intrinsic value and future growth potential, especially within the biotechnology and medical device sectors where AVITA Medical operates.

Stakeholder Impact

• Shareholders may view the director's purchase as a positive signal of confidence in the company's future.
• Employees may interpret this as a sign of stability and potential growth.
• Creditors and suppliers are unlikely to be directly impacted by this insider transaction report.

Key Dates

Keywords

AVITA Medical, RCEL, Form 4, Insider Trading, Director Purchase, Common Stock, Beneficial Ownership